[Perspectives in the treatment of allergy to latex: immunotherapy].
At present, allergy to latex is an important problem due to the severity of the symptomatology that it produces and the risk groups involved. Complete avoidance of latex is practically impossible, which is why in recent years there has been intense work on standardizing an extract in order not only to improve its clinical diagnosis but also to be able to offer a therapeutic alternative other than avoidance, such as immunotherapy. Since 1998, timely approaches to immunotherapy with latex have been published, with oral desensitization (three patients), subcutaneous (one patient) and sublingual (one patient). In every case there was an evident clinical improvement. At present, subcutaneous immunotherapy with latex, although efficient, is a high risk treatment. Sublingual immunotherapy with latex has recently been commercialized in Spain and we know of its efficacy through the results of an open test on 26 adult patients. The safety expectations are shown to be better than those for subcutaneous immunotherapy.
D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007840:Latex / Q000627:therapeutic use; D020315:Latex Hypersensitivity / Q000276:immunology / Q000628:therapy*
D007840:Latex
Perspectivas de tratamiento de la alergia al látex: inmunoterapia.